Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

News Daily News

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

L.A. McKeown

October 30, 2018

News Daily News

Aspirin Falters Yet Again in Primary Prevention: ASPREE

Michael O'Riordan

September 17, 2018

News Daily News

‘Classic’ Takotsubo? Not So Fast: Different Presentations Could Spell Diverse Prognoses

Yael L. Maxwell

August 16, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Daily News

Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention?

Todd Neale

July 20, 2018

News Daily News

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Yael L. Maxwell

June 14, 2018

News Daily News

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

Todd Neale

June 04, 2018

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

News Conference News EAS 2018

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

Yael L. Maxwell

May 16, 2018

News Industry News

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

April 25, 2018

News Daily News

Uptick Seen in Medication Adherence Among Hypertensive Patients Using Mobile App

Michael O'Riordan

April 16, 2018

News Conference News ACC 2018

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Yael L. Maxwell

March 19, 2018

News Conference News ACC 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Yael L. Maxwell

March 14, 2018

News Conference News ACC 2018

Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role

Yael L. Maxwell

March 11, 2018

News Daily News

Genetic Testing for Cardiomyopathy Less Useful for Racial Minorities

Todd Neale

March 06, 2018

Advertisement

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

Aspirin Falters Yet Again in Primary Prevention: ASPREE

‘Classic’ Takotsubo? Not So Fast: Different Presentations Could Spell Diverse Prognoses

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention?

The Patient Presenting With Chest Pain: Stress Echo Gives Coronary CTA a Run for Its Money

Biomarkers, New Data, and Revised Methods Boost Accuracy of the ACC/AHA Risk Equations

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Glucose and Beyond? Experts Debate Optimal Targets for Managing CV Risk in Diabetics

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

Uptick Seen in Medication Adherence Among Hypertensive Patients Using Mobile App

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role

Genetic Testing for Cardiomyopathy Less Useful for Racial Minorities

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content